Paxil Settlement Requires Disclosure Of Early Phase Research
The Paxil settlement between GlaxoSmithKline and New York Attorney General Eliot Spitzer sets a standard for clinical trial disclosure that goes beyond the position taken by the Pharmaceutical Research & Manufacturers of America